TrialMedical science monitor : international medical journal of experimental and clinical research2021

Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center.

Jianquan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.